Nippon Life Global Investors Americas, Inc. Charles River Laboratories International, Inc. Transaction History

Nippon Life Global Investors Americas, Inc.

$2.3 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 15, 2024	BUY	$203.52 - $273.43 $3.59 Million - $4.82 Million	17,630 Added 381.6%	22,250 $6.03 Million
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $910,648 - $1.16 Million	4,620 New	4,620 $1.01 Million

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

Vanguard Group Inc Valley Forge, PA

6.1M
Shares

$1.18 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$985 Million
0.02% of portfolio
Wellington Management Group LLP Boston, MA

3.74M
Shares

$724 Million
0.13% of portfolio
State Street Corp Boston, MA

2.13M
Shares

$412 Million
0.02% of portfolio
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA

1.94M
Shares

$375 Million
0.87% of portfolio

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.84B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nippon Life Global Investors Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nippon Life Global Investors Americas, Inc. with notifications on news.

Account